1. Home
  2. LGIH vs DRTS Comparison

LGIH vs DRTS Comparison

Compare LGIH & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$64.06

Market Cap

1.2B

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$10.94

Market Cap

978.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGIH
DRTS
Founded
2003
2015
Country
United States
Israel
Employees
N/A
121
Industry
Homebuilding
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
978.2M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
LGIH
DRTS
Price
$64.06
$10.94
Analyst Decision
Hold
Strong Buy
Analyst Count
5
3
Target Price
$75.90
$8.67
AVG Volume (30 Days)
379.1K
909.6K
Earning Date
04-28-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$1,705,504,000.00
N/A
Revenue This Year
$2.32
N/A
Revenue Next Year
$17.94
$699.98
P/E Ratio
$682.67
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.55
$2.87
52 Week High
$69.42
$11.62

Technical Indicators

Market Signals
Indicator
LGIH
DRTS
Relative Strength Index (RSI) 73.43 61.42
Support Level $41.87 $6.47
Resistance Level N/A $11.48
Average True Range (ATR) 3.06 0.65
MACD 0.86 0.05
Stochastic Oscillator 96.92 95.96

Price Performance

Historical Comparison
LGIH
DRTS

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: